Life Sciences

40+ years representing leading global life sciences companies


  • Corporate
  • Litigation
  • Regulatory
  • Intellectual Property

  • Band 1 for US Nationwide, California and Massachusetts Life Sciences in 2022 — Chambers

  • Tier 1 for Healthcare: Life Sciences in 2021 — Legal 500 US 

  • Consistently rank #1 for global biotech & pharma licensing — BioPharm Insight

  • #1 in issuer-side life sciences IPOs since 2000

  • #1 for biotech and pharma venture financings for the last decade, including in 2018 — PitchBook

  • Top 4 law firm for US biotech & pharma M&A volume since 2016 (Mergermarket + Pitchbook)

  • "Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019 — LMG Life Sciences

  • Dedicated, international practice group of 40+ professionals across the US, Europe and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies

Read more 

  • Defended more life sciences companies in shareholder litigation filed over the past ten years than any other firm

  • Achieved groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court

  • Complete wins in commercially significant drug ownership and licensing disputes 

  •  Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies

  •  Defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Food, Drug and Cosmetic Act  violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state and federal civil and criminal government enforcers

  • Experience in more than 100+ state, federal and international courts, arbitral forums and administrative bodies

  • Team includes 5 Fellows of the American College of Trial Lawyers and 20+ former Assistant US Attorneys and Department of Justice lawyers

  • Ranked #4 Most Innovative Law Firm by the Financial Times – recognized for Protecting Clients Business for litigating on behalf of our clients 

Read more 

  • Deep US and global experience providing regulatory counseling and advice on FDA, fraud & abuse, corporate compliance, contractual relationships, Sunshine Laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, MHRA and CE Marking 

  • Advise all players in the evolving ecosystem, including payors, providers, LS companies, health IT and investors

  • As connectors to the ecosystem, we counsel clients on how to launch innovative products and services

  • Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter expertise and litigation and negotiation experience

  • Counsel related to privacy and data protection, government contracts and government analytics practices provided by multidisciplinary team bolstered by industry-leading lawyers

  • Frequent contributors on groundbreaking regulatory topics at leading industry events, editorial boards and relevant media and publications

  • Market leader in life sciences — #1 in IPOs, M&A transactions, venture financings and licensing

Read more 

  • 90+ person life sciences patent team across the US and UK (90% hold PhDs)

  • The largest life sciences patent practice in the US

  • 31,000+ Patents currently under our management worldwide

  • 1,000+ IP due diligence reviews in life sciences deals/transactions

  • One of the most active IP litigation practices in the US with 500+ cases in the last 5 years

  • Complete wins in commercially significant drug ownership and licensing disputes

  • Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies 

  • Specialized branding team provides guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names

  • "Patent Strategy and Management Firm of the Year" Honoree – LMG Life Sciences (2018)

Read more 

According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier. - LMG Life Sciences

Cooley Rx

A virtual series focused on the life sciences and healthcare sectors

Learn more

Life Sciences & Healthcare Innovation Hub

Comprehensive resource for key stakeholders across the global life sciences and healthcare industry

Visit hub

Group Contacts
Kay Chandler  Partner San Diego
Christian Plaza  Partner Reston, Boston
Laura Berezin  Partner Palo Alto
Barbara Borden  Partner San Diego
Philip Bowman  Partner New York
Bill Christiansen  Partner Seattle
Ivor Elrifi  Partner New York, Boston
Koji Fukumura  Partner San Diego
Div Gupta  Partner New York
Robert L. Jones  Partner Palo Alto
Kenneth Krisko  Partner Reston, Boston
Yiming Liu  Partner in Charge – Shanghai Shanghai, Hong Kong
Chadwick Mills  Partner San Francisco
Marya Postner  Partner Palo Alto
Marc Recht  Partner Boston
Dr. Michelle Rhyu  Partner Palo Alto
Henry Stewart  Partner London
Sanya Sukduang  Partner Washington, DC
Michael Tuscan  Partner Washington, DC
Mark Weeks  Partner Palo Alto
John Wilkinson  Partner London
Elizabeth Anne Wright  Partner Brussels
Christina Zhang  Partner Shanghai
ViewHide related contacts


Listing Returned 0 Results.

ViewHide related news


Listing Returned 0 Results.

ViewHide related events


Listing Returned 0 Results.